Search and volunteer to participate in these available studies at UB. Your participation in research doesn't just benefit you, it helps advance healthcare for our entire community.

Highlighted Searches
Search Clinical Trials
Filter on any fields below
?
Compensation may include cash, checks, gift cards, debit cards, or incentives like gift baskets, technology items, or merchandise.
Showing 51 - 60 of 69 Clinical Trials
Description:
We are looking for children age 15-17 with Type 1 diabetes for a research study. The purpose of this study is to find out if a medicine called liraglutide can help control blood sugar in adolescents with Type 1 diabetes. This drug is approved by the Food and Drug Administration for the treatment of Type 2 diabetes and obesity in adults. Read More
Eligibility:
Age 15+.
Diagnosed with Type 1 diabetes for at least 1 year.
Wear an insulin pump and continuous glucose monitor to manage diabetes.
Are not pregnant or planning to become pregnant.
Do not have a history of acute pancreatitis. Have not used liraglutide in the past.
Contact(s)
LUCY MASTRANDREA
ldm@buffalo.edu
+1 716-323-0170
Description:
We are looking for children age 7+ and adults with Type 1 diabetes for a research study. The purpose of this study is to learn more about how the timing of when insulin is taken and the size of meals affects glucose levels. Read More
Eligibility:
Age 7+ (children) and age 18+ (adults).
Diagnosed with Type 1 diabetes.
Treated with multiple daily injection therapy or insulin pump.
Contact(s)
LUCY MASTRANDREA
ldm@buffalo.edu
+1 716-323-0170
Description:
This study enrolls select toddlers who were born at Oishei Children's Hospital. We will use the same tests to assess kids born at full-term as are given to preterm babies (preemies), so that we can see how their development compares. Read More
Eligibility:
Children ages 1-2 years (22-26 months).
Born at Oishei Children's Hospital.
Have been randomly selected and contacted by our team
Description:
This study enrolls babies with neonatal opioid withdrawal syndrome (NOWS). The purpose of this study is to learn about how babies with this syndrome grow and develop. This will help us learn the best way to care for babies with NOWS. Read More
Eligibility:
Infants born at 36 weeks gestation or greater
Managed for NOWS at Oishei Children's Hospital
Contact(s)
Jennifer Kachelmeyer
jldonato@buffalo.edu
+1 716-225-5794
Description:
This study enrolls children ages 4-13 who have amblyopia ("lazy eye"). The purpose of the study is to learn if vision is improved by playing a binocular game while wearing corrective glasses. Read More
Eligibility:
Children ages 4-13.
Diagnosed with amblyopia, also known as "lazy eye."
Contact(s)
Samantha Pape
spape@buffalo.edu
Description:
This study enrolls newborn infants with treatable retinopathy of prematurity (ROP). ROP is is one of the leading causes of childhood blindness worldwide. The purpose of this study is to learn if aflibercept (Eyelea) works to treat this condition. Read More
Eligibility:
Children (newborn infants).
Gestational age at birth must be 32 weeks or less, birth weight must be 1500g or less
Must have retinopathy of prematurity (ROP) that has not yet been treated.
Must weigh at least 800 g
Contact(s)
SHARON MICHALOVIC
sab1@buffalo.edu
+1 716-881-7975
Description:
The purpose of the study is to learn about the safety and efficacy of a medication called TransCon CNP in children ages 2-10 with achondroplasia. Children with achondroplasia lack this compound which is instrumental in promoting growth and ameliorating other potential medical problems. Read More
Eligibility:
Children ages 2-10 (inclusive).
Have a clinical diagnosis of ACH with genetic confirmation
Have not entered puberty yet.
Able to stand without assistance.
Caregiver willing and able to administer subcutaneous (under the skin) injections of study drug.
Contact(s)
Emily Gorman (Tabaczynski)
ecgorman@buffalo.edu
+1 716-323-0074
Description:
This study enrolls infants who are admitted to Oishei Children's hospital's Pediatric Intensive Care Unit (PICU) with bronchiolitis. The purpose of this study is to see how a medication for the condition compares with usual care. Read More
Eligibility:
Children (infants) less than 8 months of age.
Admitted to PICU with bronchiolitis.
Contact(s)
Haiping Qiao
hqiao@buffalo.edu
+1 716-323-0055
Description:
This study enrolls people ages 12 and up with Cystic Fibrosis. The purpose of this study is to give people access to a treatment for a specific type of CF when they have a critical need for it. Read More
Eligibility:
Children and adults ages 12+.
Confirmed diagnosis of CF.
Contact the study team to learn about other eligibility criteria.
Contact(s)
NADINE CACI
nadineca@buffalo.edu
+1 716-323-0070
Description:
This study enrolls children ages 0-8 with achondroplasia. The purpose of this study is to learn about how children with this condition grow. Read More
Eligibility:
Children ages 0-8.
Diagnosed with achondroplasia.
Able to stand without assistance (if the child is 24 months or older)
Contact(s)
Emily Gorman (Tabaczynski)
ecgorman@buffalo.edu
+1 716-323-0074
Showing 51 - 60 of 69 Clinical Trials
Not finding what you are looking for? Add your profile to the Buffalo Research Registry or ResearchMatch to be matched with future studies.